Cannara Biotech Inc. (LOVE) Q3 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Cannara Biotech, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.134 Good morning, everyone. Welcome to Canara Biotech's third quarter 2026 00:00:05.134 -- 00:00:10.197 earnings webcast. The three months ended May 31st, 2026. 00:00:10.197 -- 00:00:12.939 Today's presenter is Nicholas 00:00:12.939 -- 00:00:18.883 Soziak, Chief Operating Officer and Interim Chief Financial Officer of Canara Biotech. 00:00:18.883 -- 00:00:21.804 At this time, all participants are in listen-only mode. 00:00:21.804 -- 00:00:25.847 Following the prepared remarks, we will hold a question and answer session. 00:00:25.847 -- 00:00:30.373 To ask a question during this session, Please press star 11 on your telephone. 00:00:30.373 -- 00:00:34.515 You will hear an automated message confirming that your hand has been raised. 00:00:34.515 -- 00:00:38.897 To withdraw your questions, simply press star 11 again. 00:00:38.897 -- 00:00:42.098 Please be advised that today's conference is being recorded. 00:00:42.098 -- 00:00:47.460 Before we begin, please refer to slides two and three of the company's cautions 00:00:47.460 -- 00:00:52.462 regarding forward-looking statements, market and industry data, and non-GAAP and 00:00:52.462 -- 00:00:57.466 other financial measures. I will now turn the call over to Nicholas 00:00:57.466 -- 00:00:58.927 Soziak. 00:00:58.927 -- 00:01:01.607 Please go ahead, sir. 00:01:03.828 -- 00:01:08.990 Good morning, everyone, and thank you for joining me to review Canara's Q3 2026 results 00:01:08.990 -- 00:01:12.851 for the period ended May 31st, 2026. 00:01:12.851 -- 00:01:17.153 The third quarter demonstrated the depth and resilience of our business. 00:01:17.153 -- 00:01:22.094 Gross cannabis revenue increased 16% year-over-year to $44.1 million. 00:01:22.094 -- 00:01:24.837 Total net revenue reached $31.8 ...